These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10416747)

  • 1. Potential role of nitric oxide and endothelin in the pathogenesis of glaucoma.
    Haefliger IO; Dettmann E; Liu R; Meyer P; Prünte C; Messerli J; Flammer J
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S51-8. PubMed ID: 10416747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasospasm in glaucoma: clinical and laboratory aspects.
    Delaney Y; Walshe TE; O'Brien C
    Optom Vis Sci; 2006 Jul; 83(7):406-14. PubMed ID: 16840865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of the endothelin A (ET
    McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
    BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of nitric oxide in physiology and pathogenesis of ocular diseases].
    Komaszyło K; Zalewska R; Mariak Z; Wiśniewska RJ
    Klin Oczna; 2006; 108(1-3):103-6. PubMed ID: 16883953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vascular factors in glaucoma].
    Mottet B; Aptel F; Geiser M; Romanet JP; Chiquet C
    J Fr Ophtalmol; 2015 Dec; 38(10):983-95. PubMed ID: 26597554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Significance of Endothelin-1 in Glaucoma - a Short Overview].
    Gugleta K
    Klin Monbl Augenheilkd; 2018 Feb; 235(2):140-145. PubMed ID: 29448283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin antagonism as an active principle for glaucoma therapy.
    Rosenthal R; Fromm M
    Br J Pharmacol; 2011 Feb; 162(4):806-16. PubMed ID: 21054341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is primary open-angle glaucoma an ocular manifestation of systemic disease?
    Wey S; Amanullah S; Spaeth GL; Ustaoglu M; Rahmatnejad K; Katz LJ
    Graefes Arch Clin Exp Ophthalmol; 2019 Apr; 257(4):665-673. PubMed ID: 30643967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New horizons in neuroprotection.
    Naskar R; Dreyer EB
    Surv Ophthalmol; 2001 May; 45 Suppl 3():S250-5; discussion S273-6. PubMed ID: 11377444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered nitric oxide system in patients with open-angle glaucoma.
    Polak K; Luksch A; Berisha F; Fuchsjaeger-Mayrl G; Dallinger S; Schmetterer L
    Arch Ophthalmol; 2007 Apr; 125(4):494-8. PubMed ID: 17420369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects.
    Resch H; Karl K; Weigert G; Wolzt M; Hommer A; Schmetterer L; Garhöfer G
    Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):358-63. PubMed ID: 18719081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular blood flow alteration in glaucoma is related to systemic vascular dysregulation.
    Emre M; Orgül S; Gugleta K; Flammer J
    Br J Ophthalmol; 2004 May; 88(5):662-6. PubMed ID: 15090420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG).
    Dreyer EB; Grosskreutz CL
    Clin Neurosci; 1997; 4(5):270-3. PubMed ID: 9292254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma.
    Neufeld AH
    Surv Ophthalmol; 1999 Jun; 43 Suppl 1():S129-35. PubMed ID: 10416755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the ETB receptor in retinal ganglion cell death in glaucoma.
    Krishnamoorthy RR; Rao VR; Dauphin R; Prasanna G; Johnson C; Yorio T
    Can J Physiol Pharmacol; 2008 Jun; 86(6):380-93. PubMed ID: 18516102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant.
    Thanos S; Naskar R
    Exp Eye Res; 2004 Jul; 79(1):119-29. PubMed ID: 15183107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular reactivity of optic nerve head and retinal blood vessels in glaucoma--a review.
    Venkataraman ST; Flanagan JG; Hudson C
    Microcirculation; 2010 Oct; 17(7):568-81. PubMed ID: 21040122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular risk factors in glaucoma: a review.
    Yanagi M; Kawasaki R; Wang JJ; Wong TY; Crowston J; Kiuchi Y
    Clin Exp Ophthalmol; 2011 Apr; 39(3):252-8. PubMed ID: 20973906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased intraocular pressure alters the cellular distribution of HuR protein in retinal ganglion cells - A possible sign of endogenous neuroprotection failure.
    Smedowski A; Liu X; Podracka L; Akhtar S; Trzeciecka A; Pietrucha-Dutczak M; Lewin-Kowalik J; Urtti A; Ruponen M; Kaarniranta K; Varjosalo M; Amadio M
    Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):296-306. PubMed ID: 29107807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial dysfunction in glaucoma.
    Resch H; Garhofer G; Fuchsjäger-Mayrl G; Hommer A; Schmetterer L
    Acta Ophthalmol; 2009 Feb; 87(1):4-12. PubMed ID: 18507728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.